This inventor holds 1 USPTO granted patent. Top assignee: Seoul National University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Yong Sang Song - Innovator in Ovarian Cancer Diagnosis
Introduction
Yong Sang Song is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of ovarian cancer. His innovative approach utilizes microbial metagenome analysis to improve diagnostic accuracy and patient outcomes.
Latest Patents
Yong Sang Song holds a patent for a method of diagnosing ovarian cancer through microbial metagenomic analysis. This invention focuses on analyzing the content of specific bacteria or archaea-derived extracellular vesicles in human samples. By identifying changes in these microbial components, the method aims to predict the risk of ovarian cancer, facilitating early diagnosis and management.
Career Highlights
Yong Sang Song is affiliated with Seoul National University, where he conducts research and develops innovative diagnostic methods. His work has the potential to revolutionize how ovarian cancer is diagnosed and treated, addressing a critical need for early detection in this challenging area of medicine.
Collaborations
Yong Sang Song collaborates with esteemed colleagues, including Yoon-Keun Kim and Taesung Park. Their combined expertise enhances the research and development of effective diagnostic tools in the medical field.
Conclusion
Yong Sang Song's contributions to ovarian cancer diagnosis through innovative methods highlight the importance of research in improving healthcare outcomes. His work exemplifies the potential of scientific innovation to address pressing medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
